Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

The objective of this study was to test the effectiveness of ivermectin for the treatment of mouse hepatitis virus (MHV), a type 2 family RNA coronavirus similar to SARS-CoV-2. Female BALB/cJ mice were infected with 6,000 PFU of MHV-A59 (group infected, n = 20) or infected and then immediately treat...

Descripció completa

Dades bibliogràfiques

Autor principal:	Arévalo, Ana Paula (author)
Altres autors:	Pagotto, Romina (author), Pórfido Barayoli, Jorge Luis (author), Daghero Villanueva, Hellen (author), Segovia, Mercedes (author), Yamasaki, Kanji (author), Varela Cruces, María Belén (author), Hill, Marcelo (author), Verdes García, José Manuel (author), Duhalde Vega, Maite (author), Bollati-Fogolín, Mariela (author), Crispo, Martina (author)
Format:	article
Idioma:	anglès
Publicat:	2021
Matèries:	INFECCION EXPERIMENTAL RATONES IVERMECTINA CORONAVIRUS CAUSANTE DEL SINDROME RESPIRATORIO AGUDO SEVERO TERAPIA
Accés en línia:	https://hdl.handle.net/20.500.12008/48337 https://doi.org/10.1038/s41598-021-86679-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!